Anti-tumor activity of osimertinib, an irreversible...

  • Main
  • 2018 / 02
  • Anti-tumor activity of osimertinib, an irreversible...
Molecular Cancer Therapeutics 2018 / 02

Anti-tumor activity of osimertinib, an irreversible mutant-selective EGFR tyrosine kinase inhibitor, in NSCLC harboring EGFR Exon 20 Insertions

Floc'h, Nicolas, Martin, Matthew J., Riess, Jonathan W., Orme, Jonathan P, Staniszewska, Anna D., Menard, Ludovic, Cuomo, Maria Emanuela, O'Neill, Daniel J., Ward, Richard A, Finlay, M. Raymond V., Mc
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-17-0758
Date:
February, 2018
File:
PDF, 1.14 MB
english, 2018
Conversion to is in progress
Conversion to is failed